Helicobacter pylori and nonmalignant diseases.

Hdl Handle:
http://hdl.handle.net/10147/207938
Title:
Helicobacter pylori and nonmalignant diseases.
Authors:
Alakkari, Alaa; Zullo, Angelo; O'Connor, Humphrey J
Affiliation:
Department of Gastroenterology, Adelaide and Meath Hospital, Faculty of Health, Sciences of Trinity College, Dublin, Ireland.
Citation:
Helicobacter. 2011 Sep;16 Suppl 1:33-7. doi: 10.1111/j.1523-5378.2011.00878.x.
Journal:
Helicobacter
Issue Date:
1-Feb-2012
URI:
http://hdl.handle.net/10147/207938
DOI:
10.1111/j.1523-5378.2011.00878.x
PubMed ID:
21896083
Abstract:
Research published over the past year has documented the continued decline of Helicobacter pylori-related peptic ulcer disease and increased recognition of non-H. pylori, non-steroidal anti-inflammatory drugs ulcer disease--idiopathic ulcers. Despite reduced prevalence of uncomplicated PUD, rates of ulcer complications and associated mortality remain stubbornly high. The role of H. pylori in functional dyspepsia is unclear, with some authors considering H. pylori-associated nonulcer dyspepsia a distinct organic entity. There is increasing acceptance of an inverse relationship between H. pylori and gastroesophageal reflux disease (GERD), but little understanding of how GERD might be more common/severe in H. pylori-negative subjects. Research has focused on factors such as different H. pylori phenotypes, weight gain after H. pylori eradication, and effects on hormones such as ghrelin that control appetite.
Language:
eng
MeSH:
Gastrointestinal Diseases/*epidemiology/microbiology/pathology; Helicobacter Infections/*epidemiology/microbiology/pathology; Helicobacter pylori/isolation & purification/*physiology; Humans
ISSN:
1523-5378 (Electronic); 1083-4389 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorAlakkari, Alaaen_GB
dc.contributor.authorZullo, Angeloen_GB
dc.contributor.authorO'Connor, Humphrey Jen_GB
dc.date.accessioned2012-02-01T10:50:39Z-
dc.date.available2012-02-01T10:50:39Z-
dc.date.issued2012-02-01T10:50:39Z-
dc.identifier.citationHelicobacter. 2011 Sep;16 Suppl 1:33-7. doi: 10.1111/j.1523-5378.2011.00878.x.en_GB
dc.identifier.issn1523-5378 (Electronic)en_GB
dc.identifier.issn1083-4389 (Linking)en_GB
dc.identifier.pmid21896083en_GB
dc.identifier.doi10.1111/j.1523-5378.2011.00878.xen_GB
dc.identifier.urihttp://hdl.handle.net/10147/207938-
dc.description.abstractResearch published over the past year has documented the continued decline of Helicobacter pylori-related peptic ulcer disease and increased recognition of non-H. pylori, non-steroidal anti-inflammatory drugs ulcer disease--idiopathic ulcers. Despite reduced prevalence of uncomplicated PUD, rates of ulcer complications and associated mortality remain stubbornly high. The role of H. pylori in functional dyspepsia is unclear, with some authors considering H. pylori-associated nonulcer dyspepsia a distinct organic entity. There is increasing acceptance of an inverse relationship between H. pylori and gastroesophageal reflux disease (GERD), but little understanding of how GERD might be more common/severe in H. pylori-negative subjects. Research has focused on factors such as different H. pylori phenotypes, weight gain after H. pylori eradication, and effects on hormones such as ghrelin that control appetite.en_GB
dc.language.isoengen_GB
dc.subject.meshGastrointestinal Diseases/*epidemiology/microbiology/pathologyen_GB
dc.subject.meshHelicobacter Infections/*epidemiology/microbiology/pathologyen_GB
dc.subject.meshHelicobacter pylori/isolation & purification/*physiologyen_GB
dc.subject.meshHumansen_GB
dc.titleHelicobacter pylori and nonmalignant diseases.en_GB
dc.contributor.departmentDepartment of Gastroenterology, Adelaide and Meath Hospital, Faculty of Health, Sciences of Trinity College, Dublin, Ireland.en_GB
dc.identifier.journalHelicobacteren_GB
dc.description.provinceLeinster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.